A Promising New Treatment for Macular Degeneration
RPB-supported researchers have published new findings indicating they are on the verge of developing a better treatment than the anti-VEGF injections currently used for macular degeneration. In studies, a class of drugs known as MDM2 inhibitors proved highly effective at regressing the abnormal blood vessels responsible for the vision loss associated with the disease. The new approach would not require repeated injections.
Read about more of Dr. Chavala's groundbreaking, RPB-supported work.
September 16, 2013
Subscribe
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
| General Info | Grants | News & Resources |
Research to Prevent Blindness
360 Lexington Avenue, 22nd Floor
New York, NY 10017
(212) 752-4333
Copyright © 2024 Research to Prevent Blindness. All Rights Reserved.
